CAAMTECH
CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.
CAAMTECH
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Issaquah, Washington, United States
Country:
United States
Website Url:
http://www.caam.tech
Total Employee:
1+
Status:
Active
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box
Similar Organizations
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Andrew Chadeayne Founder and Chief Executive Officer @ CaaMTech
Founder and Chief Executive Officer
Robert Discordia Chief Scientific Officer @ CaaMTech
Chief Scientific Officer
2021-12-01
Founder
Investors List
Noetic Fund
Noetic Fund investment in Series A - CaaMTech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-17 | Bob Discordia Joins CaaMTech as Chief Scientific Officer |
Official Site Inspections
http://www.caam.tech Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
Unable to get host informations!!!
More informations about "CaaMTech"
CaaMTech | Pioneering Next-generation Psychedelic …
Pioneering next-generation serotonergic drugs. CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics.See details»
About CaaMTech | Leading Psychedelic Drug Development
Our Team - CaaMTech
Davis has over fifteen years of experience working with technology startups in Canada and the United States. Mike O’Shaughnessy General Counsel & Director of Intellectual Property. Michael (Mike) O’Shaughnessy has served as an …See details»
CaaMTech - Crunchbase Company Profile & Funding
Caam.tech/ 57,067; Highlights. obfuscated. Total Funding Amount . Unlock for free . Contacts 4. Employee Profiles 2. Investors 1. Similar Companies 5. Recent News & Activity. ... 139 …See details»
CaaMTech 2025 Company Profile: Valuation, Funding …
CaaMTech General Information Description. Developer of medicine discovery and optimization technology designed to focus on engineering psychedelic drugs. …See details»
CAAMTECH
CAAMTECH is a system integrator consulting firm specializing in managing technologies and supply chain networks, integrating them into a single, cohesive solution resulting in a …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and …
Sep 8, 2021 The investment provides CaaMTech with capital to advance compounds from its library into clinical trials CaaMTech Raises $22 Million for Psychedelic Drug Discovery and …See details»
CaaMTech - Neuly
Organizations CaaMTech CaaMTech. A privately held company CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small …See details»
CaaMTech LLC - Drug pipelines, Patents, Clinical trials - Synapse
The solid-state structure of the title salt/adduct (systemic name: bis{[2-(4-acetyloxy-1 H-indol-3-yl)ethyl](ethyl)propylazanium} but-2-enedioate–(E)-butenedioic acid (1/1)), 2C 17 H 25 N 2 O 2 …See details»
CaaMTech - Overview, News & Similar companies | ZoomInfo.com
Feb 16, 2022 CaaMTech contact info: Phone number: (206) 487-6917 Website: caam.tech What does CaaMTech do? CaaMTech is the foremost drug discovery and lead optimization …See details»
CaaMTech Company Profile - Office Locations, Competitors ... - Craft
CaaMTech has 5 employees at their 1 location and $22 m in total funding,. See insights on CaaMTech including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
CaaMTech’s Psychedelic Functional Unblinding Strategy Gets …
ISSAQUAH, Wash., November 14, 2024 (Newswire.com) - CaaMTech, Inc. is pleased to announce positive feedback from United States federal government regulators for its CT-4201 …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and …
September 8, 2021. CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development. CaaMTech, Inc., a leading psychedelic drug discovery company, has today …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery
Sep 8, 2021 davis@caam.tech +1.510.747.9001. Related Images. Image 1: CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development CaaMTech logo on green …See details»
CAAM Supports H2CanFly’s Mission to Propel Canada’s Hydrogen …
Nov 8, 2024 JR Hammond, Executive Director of CAAM, emphasized the strategic alignment between the two organizations, stating, “Canada has an incredible opportunity to lead in …See details»
Home | CAAM
CAAM recognizes its operations spans the diverse traditional territories of the Indigenous peoples of Canada who called this land home before the arrival of colonizing settlers. We recognize the …See details»
Center for Advanced Air Mobility | DSU College of Business
CAAM serves as a multidisciplinary hub dedicated to pioneering research, industry collaboration, and workforce development in Advanced Air Mobility (AAM). By partnering with aerospace …See details»
Contact CaaMTech about Psychedelics
Contact CaaMTech. CaaMTech is always interested in connecting with other professionals interested in our company and the rapidly progressing field of psychedelic drugs.See details»
Canada moves toward safe and responsible artificial intelligence
Mar 6, 2025 Canada was the first country in the world to introduce a national AI strategy. Since 2016, the Government of Canada has announced over $4.4 billion to support AI and digital …See details»
Updates - CaaMTech
Aug 4, 2023 January 16, 2025. CaaMTech 5-MeO-DMT Analog Research Unveils Serotonin 2A Receptor Modulation. A new research paper by scientists from CaaMTech, NIDA, RTI, UMass …See details»